91���˰涶��

Our faculty and alumni are involved in commercial ventures in several start-ups and established companies:��

• is a solar bioengineering company focused on producing traditionally plant-derived natural products from light, water and carbon dioxide.��
  
• Continuum Biosciences��is focused on developing innovative drugs to improve mitochondrial health by targeting metabolic disease and disorders.��
  
•  manufactures a proprietary form of Gamma – Glutamylcysteine (GCG) which is required to produce the powerful antioxidant Glutathione, a critical molecule required to maintain health. ��
  
• ��offers skin testing services using a proprietary in vitro human skin technology. Read about this��.��

BABS has many partnerships with industry. A number of these partnerships have been awarded , supporting partnerships with Microbiogen Pty Ltd, Royal Botanic Gardens, Domain Trust and Nutromics Pty Ltd. Our  provides protein production and purification services for academic and industry researchers.����

Other partnerships include:��

•   — a solar bioengineering company focused on producing traditionally plant-derived natural products from light, water and carbon dioxide.��
  
• Drop Bio��— an Australian digital health and biotechnology company focused on measuring and tracking chronic inflammation. Drop Bio is located at BABS allowing companies to access and utilise university facilities, forging deeper relationships between the university and industry partners.��
  
• ��—��a biotech company focused on developing improved drug discovery processes and new drug modalities.
• ��— the leading Australian industry body representing and advocating for organisations in the global biotechnology and life sciences industry. BABS faculty are represented on the NSW AusBiotech Committee.��
  
  The AusBiotech website offers key industry facts.����as an academic or student offers free access to state-based networking events, student volunteering opportunities, industry news, investments and the BiotechTalks Library covering up-to-date information on the industry.

BABS at UNSW is one of 13 national partners of��.��

The Bridge Program delivers education programs equipping early and mid-career researchers, academics and entrepreneurs with the necessary knowledge and skills to successfully commercialise Australian pharmaceutical and biotechnology research.��

The Bridge Program is supported by the government body MTPConnect, with industry-matched funding from major pharmaceutical companies and BABS at UNSW.��

Members of the BABS faculty are Program participants and steering committee members of The Bridge Program.��

��

The MTPConnect����Initiative, supported by the Medical Research Future Fund (MRFF), focuses on developing the skills and training of Australia’s medical technology, biotechnology, pharmaceutical and digital health sectors.��

The Bridge and BridgeTech REDI Program provides 20 funded industry placement fellowships per year for early and mid-career researchers, academics and entrepreneurs. Learn more about BABS����in REDI.��

��

The�� outlines the range of industry engagement activities available at UNSW. The site includes information about industry internships, external supervision, industry mentoring, funding opportunities and the UNSW-CSIRO Industry PhD Program. Visit the website.��

UNSW Founders Program��

The Founders Program is UNSW's platform to embed entrepreneurship on campus. It supports students, staff and alumni to build entrepreneurship skills and establish real companies.��

Entrepreneurial HDR (eHDR) badge for PhD students and alumni��

Earn your eHDR Badge��by completing learning modules online designed to build your skills in discovery, translation, application and commercialisation.

Research Making Impact (RMI) for academics��

RMI is a comprehensive four-week professional development program designed to support academics in collaboration with UNSW Founders and Knowledge Exchange. The program develops the confidence and capability to define the potential pathways to social, economic, cultural and environmental impact. RMI will build capabilities in critical interpersonal and technical skills required for the successful engagement of external partners, collaborators and funding bodies to make positive change in the world. Read more about��.

UNSW is a member of the����which connects motivated second and third year PhD students and early career postdoctoral fellows (mentees) in science, technology, engineering and mathematics (STEM) with influential, high-level industry leaders (mentors) in a one-year industry mentoring and professional development program.��

Current second and third year PhD students and early career postdoctoral fellows wanting to increase their understanding of industry, and build their skills, professional networks and future opportunities can visit����and enquire at the��.����

��(APR.Intern) is Australia’s only national PhD internship program spanning all sectors and disciplines. Supported by the Australian Government, Department of Education, Skills and Employment and MTPConnect’s Researcher Exchange and Development within Industry (REDI) initiative, the program connects PhD students with industry through short-term paid research projects. The program empowers students to thrive in a practical research environment. For businesses, APR.Intern is a platform to access Australia’s brightest research talent and tap into new worlds of innovation. Learn more about the experience of�� and��student testimonials.����

This is a fantastic opportunity to create a “visual elevator pitch” and develop your pitching skills. Find out more about UNSW's��3 Minute Thesis��(3MT).����

UNSW is a founding shareholder of��, Australia’s pioneer deep tech incubator supporting aspiring entrepreneurs and employees of start-ups and deep tech innovators to validate, commercialise and scale high-impact technologies globally. Seminars, workshops, mentoring and networking events are available. Cicada also supports the��Emerge tech & STEM Careers Expo��for students.

Our BABS courses benefit from the input of experts in the industry. Guest lecturers provide relevant experience, information and perspective and offer opportunities to engage with industry. Some of BABS current guest lecturers include:��

• Dr Philip Bell, Head of Research��– Microbiogen, for  Current Trends in Biotechnology
  
• Professor Alison Todd, Chief Scientific Officer & Founder of SpeeDx Pty Ltd, for  Current Trends in Biotechnology
  
• Phil Hayes-St Clair, Co-Founder & CEO of Drop Bio, for  Commercial Biotechnology
  
• Sylvie Tso, Principal of Spruson & Ferguson Lawyers Pty Ltd, for  Commercial Biotechnology
  
• Simon Uzcilas, Director of Four Hats Capital Pty Ltd, for  Commercial Biotechnology
  
• Dr James Brown, Chief Science Officer of Bondi Bio, for  Commercial Biotechnology
  
• John Martin, Chairman of BioPoint / Former CEO of Regeneus, for  Commercial Biotechnology
  
• Dr Christian Toouli, Executive Director of Bio-Link, for  Commercial Biotechnology
  
• David Burt, Director of Entrepreneurship at UNSW, for  Commercial Biotechnology
  
• Dr James Neilson, Bayer Crop Sciences, for  Commercial Biotechnology
  
• Dr Rohan Baker, Senior Principal Research Scientist at Genetic Signatures for  Medical Biotechnology